EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE ...

Lifecare ASA has received a preliminary assessment from the Norwegian Medical Products Agency (NoMA) for its application to conduct a first-in-human clinical study of its proprietary CGM system. The ...

The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system As the first fully implantable device in the category, ...

The developer of GluCurve Pet CGM anticipates a high demand for the product.

Adapet has launched a veterinary-specific continuous glucose monitoring (CGM) system that revolutionizes diabetes care for pets by providing real-time, accurate, and stress-free glucose tracking for ...

Dive deeper with STAT+. Gain unlimited access to expert analysis, newsletters, events, and news alerts.

On Friday, Senseonics, maker of the implantable continuous glucose monitoring system Eversense, announced a new program geared towards patients with high-deductible insurance plans or plans that don’t ...

Credit: Ascensia Diabetes Care. Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management. The FDA has designated the Eversense 365 ...

With more than 10 years of pioneering CGM market leadership in AID integration, Dexcom is the most studied CGM brand with AID capabilities and the clear choice for powering AID systems 3,4 The ...

Please provide your email address to receive an email when new articles are posted on . The Tandem Mobi automated insulin delivery system can be integrated with ...